These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 25828638)
1. Trends and patterns of five antihypertensive drug classes between 2007 and 2012 in China using hospital prescription data. Xu H; He Y; Xu L; Yan X; Dai H Int J Clin Pharmacol Ther; 2015 Jun; 53(6):430-7. PubMed ID: 25828638 [TBL] [Abstract][Full Text] [Related]
2. Consumption and costs of antihypertensive drugs in Mexico: are diuretic agents a standing technological trajectory? Altagracia-Martínez M; Kravzov-Jinich J; Guadarrama-Atrizco MD; Rubio-Poo C; Wertheimer AI Res Social Adm Pharm; 2006 Mar; 2(1):22-37. PubMed ID: 17138499 [TBL] [Abstract][Full Text] [Related]
3. Antihypertensive prescriptions over a 10-year period in a large Chinese population. Wong MC; Tam WW; Cheung CS; Tong EL; Sek AC; Cheung NT; Yan BP; Yu CM; Griffiths SM Am J Hypertens; 2013 Jul; 26(7):931-8. PubMed ID: 23591987 [TBL] [Abstract][Full Text] [Related]
4. Antihypertensive drug prescription trends at the primary health care centres in Bahrain. Jassim al Khaja KA; Sequeira RP; Wahab AW; Mathur VS Pharmacoepidemiol Drug Saf; 2001 May; 10(3):219-27. PubMed ID: 11501335 [TBL] [Abstract][Full Text] [Related]
5. Pattern analysis and variations in the utilization of antihypertensive drugs in Taiwan: a six-year study. Huang LY; Shau WY; Chen HC; Su S; Yang MC; Yeh HL; Lai MS Eur Rev Med Pharmacol Sci; 2013 Feb; 17(3):410-9. PubMed ID: 23426547 [TBL] [Abstract][Full Text] [Related]
6. How well have practices followed guidelines in prescribing antihypertensive drugs: the role of health insurance. Guo JD; Liu GG; Christensen DB; Fu AZ Value Health; 2003; 6(1):18-28. PubMed ID: 12535235 [TBL] [Abstract][Full Text] [Related]
7. Prevalence and management of hypertension in primary care in Portugal. Insights from the VALSIM study. Cortez-Dias N; Martins S; Belo A; Fiuza M; Rev Port Cardiol; 2009 May; 28(5):499-523. PubMed ID: 19650569 [TBL] [Abstract][Full Text] [Related]
8. Hypertension control in community health centers across China: analysis of antihypertensive drug treatment patterns. Wang Z; Wang X; Chen Z; Wang W; Zhu H; Chen W; Zhu M; Hu S; Staessen JA; Liu L; Fodor JG; Am J Hypertens; 2014 Feb; 27(2):252-9. PubMed ID: 24108862 [TBL] [Abstract][Full Text] [Related]
9. Frequency and Patterns of Prescribing Antihypertensive Agents in Outpatient Kidney Transplant Recipients Among Six Cities in China from 2011 to 2018. Hou W; Li D; Shen S; Lin J; Lou A; Wen A Clin Ther; 2021 Mar; 43(3):602-612. PubMed ID: 33637331 [TBL] [Abstract][Full Text] [Related]
10. Patterns of prescription antihypertensive drug utilization and adherence to treatment guidelines in the city of Novi Sad. Tomas A; Tomić Z; Milijasević B; Ban M; Horvat O; Vukmirović S; Sabo A Vojnosanit Pregl; 2016 Jun; 73(6):531-7. PubMed ID: 27498444 [TBL] [Abstract][Full Text] [Related]
11. The patterns of antihypertensive drug prescription by cardiologists in Kerman province of Iran, 2006. Sepehri G; Talebizadeh N; Mirzazadeh A; Mohsenbeigi M Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):180-5. PubMed ID: 18001003 [TBL] [Abstract][Full Text] [Related]
12. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs. Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973 [TBL] [Abstract][Full Text] [Related]
13. Antihypertensive persistence and drug class. Marentette MA; Gerth WC; Billings DK; Zarnke KB Can J Cardiol; 2002 Jun; 18(6):649-56. PubMed ID: 12107422 [TBL] [Abstract][Full Text] [Related]
14. Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management. Petrella R; Michailidis P Clin Ther; 2011 Sep; 33(9):1190-203. PubMed ID: 21885126 [TBL] [Abstract][Full Text] [Related]
15. Uptake of angiotensin II receptor blockers in the treatment of hypertension. Greving JP; Denig P; van der Veen WJ; Beltman FW; Sturkenboom MC; de Zeeuw D; Haaijer-Ruskamp FM Eur J Clin Pharmacol; 2005 Jul; 61(5-6):461-6. PubMed ID: 15912393 [TBL] [Abstract][Full Text] [Related]
16. Trends in the use of antihypertensive drugs by outpatients with diabetes in Taiwan, 1997-2003. Chiang CW; Chen CY; Chiu HF; Wu HL; Yang CY Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):412-21. PubMed ID: 17252613 [TBL] [Abstract][Full Text] [Related]
17. Discrepancies between prescribed and defined daily doses: a matter of patients or drug classes? Grimmsmann T; Himmel W Eur J Clin Pharmacol; 2011 Aug; 67(8):847-54. PubMed ID: 21544512 [TBL] [Abstract][Full Text] [Related]
18. Patterns of antihypertensive prescribing, discontinuation and switching among a Hong Kong Chinese population from over one million prescriptions. Wong MC; Jiang JY; Lam AT; Fung H; Griffiths S; Mercer SW J Hum Hypertens; 2008 Oct; 22(10):714-6. PubMed ID: 18650836 [TBL] [Abstract][Full Text] [Related]
19. Pharmacoepidemiology of antihypertensive drugs in primary care setting of Bahrain between 1998 and 2000. Al Khaja KA; Sequeira RP Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):741-8. PubMed ID: 16342299 [TBL] [Abstract][Full Text] [Related]
20. Analysis of prescription status of antihypertensive drugs in Chinese patients with hypertension based on real-world study. Yang R; Tang J; Kuang M; Liu H Ann Med; 2023 Dec; 55(1):276-284. PubMed ID: 36594446 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]